EMBERA NEUROTHERAPEUTICS, INC.

Profile

Company Names

EMBERA NEUROTHERAPEUTICS, INC.
EMBERA NEUROTHERAPEUTICS INC

Addresses

365 BOSTON POST ROAD, SUITE 212, SUDBURY, MA 01776

29 BABE RUTH DRIVE, SUDBURY, MA 01776

1725 CLAIBORNE AVE, STE 108, SHREVEPORT, LA 71103

BIOSPACE 1, 2031 KINGS HIGHWAY, SHREVEPORT, LA 71103

BIOSPACE 1, 2031 KINGS HIGHWAY, SHREVEPORT, LA 71103

Phone Numbers

978-579-4156
318-213-0198
(617) 719-9406
(318) 213-0198

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DE

Total Amount Raised:

$14,735,278.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2019-09-19 
$6,128,235.00 
$8,282,455.00 
$2,154,220.00 
Equity 
4
2014-12-19 
$4,511,399.00 
$6,641,944.00 
$2,130,545.00 
Equity 
3
2011-08-02 
$3,505,644.00 
$4,505,800.00 
$1,000,156.00 
Equity 
2
2009-10-22 
$490,000.00 
$880,000.00 
$390,000.00 
 
1
2009-05-15 
$100,000.00 
$100,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROSS 
 
BARRETT 
DIRECTOR
CALOSYN PHARMA, INC.   |  ESPERANCE PHARMACEUTICALS, INC   |  EMBERA NEUROTHERAPEUTICS, INC.   |  NUME HEALTH, LLC   |  NUPOTENTIAL, INC.   |  MICROBIOME THERAPEUTICS, LLC   |  A28 THERAPEUTICS, INC.   |  CANCER FOCUS FUND II, LP
ROSS 
P. 
BARRETT 
DIRECTOR
EMBERA NEUROTHERAPEUTICS INC   |  SOUTHEAST VENTURE HOLDINGS, LLC   |  CONGRESS AVENUE EQUITY ARMOR, LP   |  LAGNIAPPE LABS, LLC   |  CANCER FOCUS FUND, LP   |  CALOSYN PHARMA, INC.
JOHN 
 
BEAIRD 
DIRECTOR
EMBERA NEUROTHERAPEUTICS, INC.   |  CYBERREEF SOLUTIONS, INC.
NICHOLAS 
 
GOEDERS 
EXECUTIVE OFFICER, DIRECTOR
EMBERA NEUROTHERAPEUTICS, INC.
NICHOLAS 
E. 
GOEDERS 
DIRECTOR
EMBERA NEUROTHERAPEUTICS INC
FRANZ 
 
HEFTI 
DIRECTOR
EMBERA NEUROTHERAPEUTICS INC   |  QR PHARMA, INC.   |  EMBERA NEUROTHERAPEUTICS, INC.   |  COGNITION THERAPEUTICS INC   |  ACUMEN PHARMACEUTICALS, INC.   |  ALZHEON, INC.   |  SPINOGENIX, INC.
ROBERT 
 
LINKE 
EXECUTIVE OFFICER, DIRECTOR
EMBERA NEUROTHERAPEUTICS INC   |  EMBERA NEUROTHERAPEUTICS, INC.   |  OSMOL THERAPEUTICS, INC.
ROBERT 
B. 
LINKE 
EXECUTIVE OFFICER, DIRECTOR
EMBERA NEUROTHERAPEUTICS, INC.
JOSEPH 
 
LOVETT 
DIRECTOR
ESPERANCE PHARMACEUTICALS, INC   |  EMBERA NEUROTHERAPEUTICS, INC.   |  CALOSYN PHARMA, INC.   |  DOWLEY SECURITY SYSTEMS, INC.   |  BIOCEPTIVE, INC.
JOSEPH 
P. 
LOVETT 
DIRECTOR
EMBERA NEUROTHERAPEUTICS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-12-30
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-19 
2019-10-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-19 
2015-09-29
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
2015-01-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
2011-08-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-02 
2010-03-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-10-22 
2009-11-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-10-22 
2009-05-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-05-15 
2009-05-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-05-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
WITHERSPOON PARTNERS
226591